Some evidence suggests that individuals with impaired glucose tolerance may exhibit different GLP-1 responses to dietary stimuli compared to metabolically healthy individuals, though specific data regarding allulose in this context remain limited
Weight cycling and cancer: weighing the evidence of intermittent caloric restriction and cancer risk
It directly signals your body to upregulate the production of both collagen AND elastin
This can contribute to endothelial dysfunction, making arteries less responsive and creating conditions that favor inflammation and plaque formation
However, when the semaglutide shortage ended in February 2025, some compounders and DTC platforms continued producing compounded GLP-1s, resulting in regulatory scrutiny and legal action from the FDA and semaglutide manufacturer Novo Nordisk
The implications of GLP-1 drugs are far-reaching: if issues of cost and access can be managed, these medications could significantly reduce the burden of type 2 diabetes, cardiovascular disease, and obesity-related complications on a global scale